Notice of Intent to Sole Source - Abbott Laboratories Inc. - Fort Jackson, SC
Inactive on SAM.gov — responses were due 24 Aug 2026 · Unrestricted (full and open) · Defense Health Agency (DHA), DoD · Columbia, SC · NAICS 325413 · Solicitation PANHCA26P0000031152_Modified
Following NAICS 325413? Get new solicitations in it by email as they post — no account needed.
SAM.gov marked this notice inactive — responses were due 24 August 2026.
No award notice on SAM.gov yet. Not every award is posted there, so this does not mean it went unawarded.
Email me when the award is announced. One email, when SAM.gov posts the award notice. Not every award is posted there; if none appears within six months we'll tell you and stop. No account needed.
This one has closed. We'll email you when new NAICS 325413 (In-Vitro Diagnostic Substance Manufacturing) solicitations post — the first email lists what is open right now, then at most once a week, only when something new posts. No account needed; unsubscribe in a click.
Description
****This is an updated Notice of Intent to Sole Source - Original Posting Notice ID: PANHCA26P0000031152 was cancelled to add the redacted Justification and Approval (J&A) and update response time**** This notice is being published in accordance with Revolutionary FAR Overhaul (RFO) Federal Acquisition Regulation (FAR) Subpart 5.101 requiring dissemination of information for proposed contract actions. This is a Notice of Intent to Sole Source and is not a request for competitive quotes/proposals. The Defense Health Agency Contracting Activity Healthcare Contracting Division, Southeast (DHACA-HCD-SE) is issuing this Notice of Intent (NOI) to inform industry contractors of the Government s intent to execute a Sole Source out-of-scope bilateral modification to an existing Firm-Fixed-Price, commercial Cost-Per-Reportable-Result (CPRR) contract, W91YTZ25C0003, awarded to Abbott Laboratories, Inc., for Moncrief Army Health Clinic, Fort Jackson, South Carolina. In accordance with RFO FAR 6.103-1, Only one responsible source and no other supplies or services will satisfy agency requirements. This contract action is to increase the estimated quantities and overall ceiling funding for Option years 1, 2, 3, and 4 for Chemistry/Immunochemistry analyzers, reagents, consumables, calibrations, and control material, in support of Defense Health Agency and Department of the Army mission. The North American Industry Classification System (NAICS) for this requirement is 325413, In-vitro diagnostic substances manufacturing. The Small Business Administration (SBA) size standard is 1,250 employees. The Product/Service Code (PSC) is 6550, In Vitro Diagnostic Substances, Reagents, Test Kits and Sets. This NOI is neither a formal solicitation, nor a request for competitive proposals. No solicitation document is available, and telephone requests will not be honored. No award will be made based on unsolicited quotations or offers received in response to this notice. Any response to this notice must show clear, compelling, and convincing evidence that competition will be advantageous to the Government. The intent of this synopsis is for informational purposes only. Information received will normally be considered solely for the purpose of determining whether to conduct competitive procurement. A determination by the Government to not compete this action based on this notice is solely within the discretion of the Government. All inquiries and concerns must be addressed in writing via email to Donna Rodriguez, email: donna.d.rodriguez.civ@health.mil and Mary Shifflett, email: mary.e.shifflett2.civ@health.mil. All interested parties who are responsible, certified, and capable may identify their interest and may submit a Capabilities Statement on company letterhead no later than 12:00 P.M., Eastern Daylight Time (EDT), on August 24,2026, to the above listed contacts. The interested parties bear full responsibility to ensure complete, timely transmission and confirmation of receipt.
Documents in the solicitation package
1 file is attached to this notice.
A.02_Justification and Approval_W91YTZ25C0003_Redacted.pdf
FedSift reads the full solicitation package — every attachment — and pre-extracts the compliance matrix, evaluation factors, key risks, win themes and deal-breakers, each with a verbatim quote and the exact PDF page it came from. It scores the opportunity against your company profile, tells you whether to bid as prime or sub, and ranks teaming partners who could close your gaps.
Source: this notice on SAM.gov. FedSift republishes public federal procurement data and is not affiliated with the U.S. Government. Always confirm dates and requirements against SAM.gov before responding.
